β受体阻滞剂-话题@MedSci

#β受体阻滞剂#

107篇内容 | 4882人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1274984, encodeId=35d912e4984ae, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=β受体阻滞剂治疗高血压的临床应用建议, objectType=article, longId=177194, objectId=81581e7194c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81581e7194c3, replyNumber=0, likeNumber=90, createdTime=2019-08-09, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81581e7194c3, moduleTitle=β受体阻滞剂治疗高血压的临床应用建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81581e7194c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274983, encodeId=73dd12e498366, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, objectType=article, longId=168960, objectId=a861168960b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a861168960b7, replyNumber=0, likeNumber=91, createdTime=2019-06-24, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a861168960b7, moduleTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a861168960b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274982, encodeId=ee9e12e498247, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率, objectType=article, longId=166800, objectId=cf8f166800fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf8f166800fa, replyNumber=0, likeNumber=102, createdTime=2019-05-27, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf8f166800fa, moduleTitle=2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf8f166800fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274981, encodeId=6ad012e49812c, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=β受体阻滞剂在高血压应用中的专家共识, objectType=article, longId=165739, objectId=3a78165e3980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a78165e3980, replyNumber=0, likeNumber=86, createdTime=2019-05-10, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a78165e3980, moduleTitle=β受体阻滞剂在高血压应用中的专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a78165e3980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274980, encodeId=728012e498002, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布, objectType=article, longId=162908, objectId=a3c81629085d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c81629085d, replyNumber=0, likeNumber=82, createdTime=2019-03-26, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c81629085d, moduleTitle=2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3c81629085d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274979, encodeId=b6e912e4979f9, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率, objectType=article, longId=160232, objectId=cfc5160232ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc5160232ec, replyNumber=0, likeNumber=78, createdTime=2019-02-18, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc5160232ec, moduleTitle=AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc5160232ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274978, encodeId=864412e4978aa, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, objectType=article, longId=157152, objectId=5a6115e152ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a6115e152ee, replyNumber=0, likeNumber=85, createdTime=2019-01-02, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a6115e152ee, moduleTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a6115e152ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274977, encodeId=dc1612e497729, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, objectType=article, longId=154613, objectId=fd541546136d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd541546136d, replyNumber=0, likeNumber=89, createdTime=2018-11-30, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd541546136d, moduleTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd541546136d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274976, encodeId=f24812e497624, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, objectType=article, longId=152882, objectId=97e515288294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e515288294, replyNumber=0, likeNumber=74, createdTime=2018-11-08, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e515288294, moduleTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e515288294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274975, encodeId=73f712e497525, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, objectType=article, longId=151198, objectId=77581511982e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77581511982e, replyNumber=0, likeNumber=57, createdTime=2018-10-18, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77581511982e, moduleTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77581511982e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274974, encodeId=91d912e49744f, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, objectType=article, longId=151179, objectId=10aa1511e908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10aa1511e908, replyNumber=0, likeNumber=87, createdTime=2018-10-18, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10aa1511e908, moduleTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10aa1511e908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274973, encodeId=aa4012e497364, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, objectType=article, longId=150404, objectId=af2015040478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af2015040478, replyNumber=0, likeNumber=82, createdTime=2018-10-07, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af2015040478, moduleTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af2015040478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274972, encodeId=511012e4972ac, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, objectType=article, longId=150169, objectId=8923150169bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8923150169bb, replyNumber=0, likeNumber=81, createdTime=2018-10-02, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8923150169bb, moduleTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8923150169bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274971, encodeId=aaba12e4971e6, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, objectType=article, longId=149357, objectId=2f0e14935ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f0e14935ebb, replyNumber=0, likeNumber=98, createdTime=2018-09-24, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f0e14935ebb, moduleTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f0e14935ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274970, encodeId=0c7012e497014, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, objectType=article, longId=141676, objectId=ab751416e6bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab751416e6bd, replyNumber=0, likeNumber=101, createdTime=2018-06-28, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab751416e6bd, moduleTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab751416e6bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274969, encodeId=7fa112e49695a, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险, objectType=article, longId=135004, objectId=878013500472, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878013500472, replyNumber=0, likeNumber=106, createdTime=2018-04-13, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878013500472, moduleTitle=Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=878013500472)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274968, encodeId=674412e4968ec, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=糖尿病患者：我能不能用β受体阻滞剂？, objectType=article, longId=133855, objectId=52b31338551a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52b31338551a, replyNumber=0, likeNumber=68, createdTime=2018-03-31, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52b31338551a, moduleTitle=糖尿病患者：我能不能用β受体阻滞剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52b31338551a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274967, encodeId=14c012e4967df, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Eur Heart J Acute Cardiovasc Care：长期应用β受体阻滞剂是否会增加STEMI患者心源性休克的发生风险？, objectType=article, longId=132917, objectId=e0bb13291e44, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0bb13291e44, replyNumber=0, likeNumber=93, createdTime=2018-03-21, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0bb13291e44, moduleTitle=Eur Heart J Acute Cardiovasc Care：长期应用β受体阻滞剂是否会增加STEMI患者心源性休克的发生风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0bb13291e44)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274966, encodeId=4b8312e49665b, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=ACC 2018：CECCY研究：β受体阻滞剂对化疗心肌毒性是否有预防价值仍有待进一步探讨, objectType=article, longId=132572, objectId=d3d61325e2bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3d61325e2bf, replyNumber=0, likeNumber=77, createdTime=2018-03-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3d61325e2bf, moduleTitle=ACC 2018：CECCY研究：β受体阻滞剂对化疗心肌毒性是否有预防价值仍有待进一步探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3d61325e2bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274965, encodeId=e9ff12e4965b8, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Eur Heart J：β受体阻滞剂能改善心衰伴LVEF降低患者的预后, objectType=article, longId=125897, objectId=d55112589e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d55112589e5c, replyNumber=0, likeNumber=106, createdTime=2018-01-09, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d55112589e5c, moduleTitle=Eur Heart J：β受体阻滞剂能改善心衰伴LVEF降低患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d55112589e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

β受体阻滞剂

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

β受体阻滞剂治疗高血压的临床应用建议

2019-08-09

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性

2019-06-24

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率

2019-05-27

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

β受体阻滞剂在高血压应用中的专家共识

2019-05-10

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布

2019-03-26

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率

2019-02-18

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系

2019-01-02

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？

2018-11-30

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系

2018-11-08

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率

2018-10-18

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险

2018-10-18

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响

2018-10-07

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？

2018-10-02

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择

2018-09-24

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！

2018-06-28

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险

2018-04-13

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

糖尿病患者：我能不能用β受体阻滞剂？

2018-03-31

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Eur Heart J Acute Cardiovasc Care：长期应用β受体阻滞剂是否会增加STEMI患者心源性休克的发生风险？

2018-03-21

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

ACC 2018：CECCY研究：β受体阻滞剂对化疗心肌毒性是否有预防价值仍有待进一步探讨

2018-03-17

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Eur Heart J：β受体阻滞剂能改善心衰伴LVEF降低患者的预后

2018-01-09

科室
- - 订阅+
  - 更多科室
工具
服务